One Health Aotearoa Symposium 2022

Our 8th symposium was held Tuesday 6 and Wednesday 7 December 2022 in Wellington and online.

The annual One Health Aotearoa Symposium aims to bring together experts from the fields of animal, human and environmental health in order to address important One Health issues in Aotearoa New Zealand.

Programme for the 8th Symposium

Session 1:

  • Plenary: Alison Mather, Quadram Institute (UK)
    Global epidemiology of antimicrobial resistance: Where and for what should we be looking
  • Isabelle Pattis, ESR
    Antimicrobial resistance in Ōtautahi’s wastewater
  • Aline Parolin, Massey University
    Antimicrobial resistance and genetic background of non-typhoidal Salmonella enterica strains isolated from Brazil
  • Sophie van Hamelsveld, ESR
    Bacterial response to antibiotics altered by emerging organic contaminants, implications for environmental transmission of antibiotic resistance
  • Sara Burgess/Adrian Cookson, Massey University
    Potential sources, transmission routes and vectors of antimicrobial resistant Escherichia coli isolated from pastoral and freshwater sites
  • Emma Voss, University of Otago
    New Zealand wide survey of Staphylococcus aureus strains in dairy cows shows conserved multidrug resistance and dominance of endemic ST1 strain type

Session 2:

  • Plenary: Philippa Howden-Chapman, University of Otago, Wellington
    Cities under COVID-19: a systems perspective
  • Sue Huang, ESR
    Shivers community and household cohorts in response to COVID-19 pandemic and influenza infection in New Zealand
  • Sandra Steele, University of Melbourne
    Operationalisation of One Health: preparedness and response to EIDs and zoonoses in Australia
  • Sharla McTavish, University of Otago, Wellington
    Socioeconomic and ethnic disparities associated with severe community-acquired pneumonia in Aotearoa

Session 3:

  • Jens Hammerl, German Federal Institute for Risk Assessment
    Emergence of multidrug-resistant Vibrio parahaemolyticus in imported seafood in Germany: Genetic basis and transmissibility of resistance plasmids
  • Megan Devane, ESR
    Exploring the bacterial community signatures in waters contaminated with faecal sources
  • Holly Gray, Massey University
    The genetic epidemiology of extended-spectrum beta-lactamase producing E. coli within the Manawatū region
  • Mike Bunce, ESR/DOC
    The multiple applications of environmental DNA (eDNA) technologies across Aotearoa New Zealand

Session 4:

Session 5: OHA Poster Pitch and Poster Session

Session 6:

  • Plenary: David Aanensen, University of Oxford
    Enhancing AMR surveillance with integrated genomic data
  • Rob Lake, ESR
    Global burden of foodborne disease – a World Health Organization initiative
  • Lisa Hulme-Moir, Gribbles Veterinary Laboratories
    Salmonellosis in cats and dogs in Aotearoa New Zealand
  • Stefan Hertwig, German Federal Institute for Risk Assessment
    Yersinia infections in Europe: What is known thus far and problems we face
  • Joanne Kingsbury and Kerushini Govender, ESR and Ministry for Primary Industries
    Recent incursion of Salmonella enteritidis affecting humans, animals, and poultry
  • Scott McDougall, Cognosco, Anexa Veterinary Services
    Detection of MRSA of likely human origin in a dairy herd
  • Jan Powell, ESR
    Organ-on-a-chip for studying zoonotic pathogens

Session 7:

  • Patrick Biggs, Massey University
    The genomics of the New Zealand Mycoplasma bovis outbreak
  • Amy Burroughs, Ministry for Primary Industries
    Are we there yet? Determining the evidence required to demonstrate Mycoplasma bovis eradication from Aotearoa
  • Peter Adu, Victroria University of Wellington
    Investigating psychological and demographic factors linked to COVID-19 vaccine uptake willingness and immune status in India and New Zealand
  • Amanda Kvalvsig, University of Otago, Wellington
    Will the 2020s be the decade of elimination in Aotearoa New Zealand?

Session 8:

  • Plenary: Anneka Anderson, University of Auckland
    Using rheumatic fever as a lens to elucidate health inequities for Māori and Pacific people in Aotearoa
  • Jackie Benschop, Massey University
    Novel profiles and risk factors for leptospirosis in Aotearoa
  • Dianne Sika-Paotonu, University of Otago, Wellington
    Drug design and addressing health Inequalities – towards a new penicillin for ARF and RHD prevention

Session 9:

  • Te Pora Thompson and Nigel French, Te Niwha Co-directors
    Te Niwha – the Infectious Diseases Research Platform
  • Iain Lamont and Kristen Dyet, One Health Aotearoa Co-directors
    One Health Aotearoa update

Plenary speakers

  • Alison Mather (Quadram, UK)
  • Anneka Anderson (Auckland)
  • David Aanensen (Oxford, UK)
  • Philippa Howden-Chapman (Otago)
  • Andrew Old (Ministry of Health)

Invited speakers

  • Jackie Benshop (Massey)
  • Amanda Kvalvsig (Otago)
  • Dianne Sika-Paotonu (Otago)
  • Isabelle Pattis (ESR)
  • Jens Hammerl (German Federal Institute for Risk Assessment)
  • Joanne Kingsbury (ESR)
  • Kerushini Govender (MPI)
  • Michael Bunce (ESR)
  • Patrick Biggs (Massey)
  • Rob Lake (ESR)
  • Sandra Steel (Melbourne)
  • Sara Burgess (Massey)
  • Stefan Hertwig (German Federal Institute for Risk Assessment)

Themes of the 8th OHA Symposium

  • Infectious disease eradication
  • Emerging infectious diseases & health inequality
  • Antimicrobial resistance
  • Environmental and water health
  • Mātauranga Māori and mahinga kai
  • Endemic zoonotic diseases
  • Biosecurity prevention and preparedness
  • Other One Health topics

OHA Symposium archives